Jerome Kerzerho
Orsay, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
A detoxified TLR4 agonist inhibits tumour growth and lung metastasis of osteosarcoma by promoting CD8+ cytotoxic lymphocyte infiltration.
Journal: BJC reports
Published: November 25, 2024
Diversity, Complexity, and Specificity of Bacterial Lipopolysaccharide (LPS) Structures Impacting Their Detection and Quantification.
Journal: International journal of molecular sciences
Published: February 09, 2024
A TLR4 Agonist Induces Osteosarcoma Regression by Inducing an Antitumor Immune Response and Reprogramming M2 Macrophages to M1 Macrophages.
Journal: Cancers
Published: July 21, 2023
A systemically administered detoxified TLR4 agonist displays potent antitumor activity and an acceptable tolerance profile in preclinical models.
Journal: Frontiers in immunology
Published: November 08, 2022
Large-scale mapping of the Ebola NP and GP proteins reveals multiple immunoprevalent and conserved CD4 T-cell epitopes.
Journal: Cellular & molecular immunology
Published: April 14, 2020
High Therapeutic Efficacy of a New Survivin LSP-Cancer Vaccine Containing CD4+ and CD8+ T-Cell Epitopes.
Journal: Frontiers in oncology
Published: August 02, 2018
Immunoprevalence and magnitude of HLA-DP4 versus HLA-DR-restricted spontaneous CD4(+) Th1 responses against telomerase in cancer patients.
Journal: Oncoimmunology
Published: September 02, 2015
The signal peptide of the tumor-shared antigen midkine hosts CD4+ T cell epitopes.
Journal: The Journal of biological chemistry
Published: April 05, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026